Citadel Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.29M Buy
+381,389
New +$9.29M ﹤0.01% 1419
2025
Q1
Sell
-79,357
Closed -$1.87M 5924
2024
Q4
$1.87M Buy
79,357
+3,107
+4% +$73.2K ﹤0.01% 2676
2024
Q3
$1.95M Buy
76,250
+64,124
+529% +$1.64M ﹤0.01% 2535
2024
Q2
$285K Sell
12,126
-295,297
-96% -$6.93M ﹤0.01% 4346
2024
Q1
$8.84M Buy
+307,423
New +$8.84M ﹤0.01% 1362
2023
Q4
Sell
-128,754
Closed -$3.59M 5871
2023
Q3
$3.59M Sell
128,754
-55,557
-30% -$1.55M ﹤0.01% 1889
2023
Q2
$6.28M Buy
184,311
+135,327
+276% +$4.61M ﹤0.01% 1543
2023
Q1
$1.47M Sell
48,984
-71,718
-59% -$2.16M ﹤0.01% 2811
2022
Q4
$3.41M Sell
120,702
-287,014
-70% -$8.1M ﹤0.01% 2136
2022
Q3
$13.4M Sell
407,716
-61,789
-13% -$2.03M ﹤0.01% 1078
2022
Q2
$14.8M Buy
469,505
+436,404
+1,318% +$13.7M ﹤0.01% 1020
2022
Q1
$1.52M Buy
+33,101
New +$1.52M ﹤0.01% 3308
2021
Q4
Sell
-306,859
Closed -$22.9M 6418
2021
Q3
$22.9M Buy
306,859
+221,243
+258% +$16.5M ﹤0.01% 829
2021
Q2
$7.92M Buy
85,616
+50,490
+144% +$4.67M ﹤0.01% 1663
2021
Q1
$3.12M Buy
+35,126
New +$3.12M ﹤0.01% 2682
2020
Q4
Sell
-8,115
Closed -$517K 5047
2020
Q3
$517K Buy
+8,115
New +$517K ﹤0.01% 3474
2020
Q2
Sell
-20,794
Closed -$650K 4607
2020
Q1
$650K Buy
+20,794
New +$650K ﹤0.01% 3201
2019
Q4
Sell
-41,964
Closed -$1.24M 4602
2019
Q3
$1.24M Buy
41,964
+19,565
+87% +$578K ﹤0.01% 2740
2019
Q2
$772K Buy
+22,399
New +$772K ﹤0.01% 3190
2019
Q1
Sell
-45,979
Closed -$1.1M 4501
2018
Q4
$1.1M Buy
+45,979
New +$1.1M ﹤0.01% 2705
2018
Q3
Sell
-34,445
Closed -$1M 4256
2018
Q2
$1M Buy
+34,445
New +$1M ﹤0.01% 2648